Aibo Medical Announces Intent to Acquire Controlling Stake of at Least 51% in Demey Medical

Gelonghux1 January 20｜Eyebright Medical (688050.SH) announced that it has signed a "Letter of Intent for Investment" with Delta Medical (Chongqing) Medical Technology Co., Ltd. and its founder Jianbo Li. The company plans to acquire no less than 51% of Delta Medical's equity and gain control through a combination of acquisition loans and self-owned funds. Delta Medical is a national high-tech enterprise and a "specialized, refined, distinctive, and innovative" little giant enterprise, owning 276 patented technologies, with product lines covering the entire sports health field. Eyebright Medical intends to foster new profit growth points through this acquisition, extending its existing R&D advantages and management system into high-potential sub-sectors such as sports medicine. This transaction does not constitute a related party transaction, nor does it constitute a major asset restructuring.